Carbamazepine
Overview
Carbamazepine is a dibenzapine derivative with antiepileptic and anticonvulsant properties. Carbamazepine is closely related to Imipramine and other antidepressants. Carbamazepine is a tricyclic compound effective in the treatment of bipolar effective disoredrs. It was initally marketed for the treatment of trigeminal neuralgia but has proved useful for epilepsy as well. Carbamazepine is now used as a drug of choice for simple and complex partial seizures and for tonic clonic seizures. It is also used for the management of certain types of nerve pain.
Categories
- 24 Psychotherapeutic drugs
- 24.2 Drugs used in mood disorders
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Oral absorption of Carbamazepine is found to be 84% ±12. Volume of distribution is found to be 0.8-2 l/Kg and plasma protien binding is 54-80%. Renal Excretion accounts for 1% (unchanged) and plasma half life is 30-40 hr.
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Carbamazepine's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
100 to 200 mg | 150 (150) | 12 hourly | PO | As initial dose. |
800 to 1200 mg | 1000 (1000) | As recommended. | PO | In div.doses. Maximum dose: for 12-15 years; 1000 mg/day. for > 15 years; 1.6-2.4 g/day. |
Paedriatic Dosage (20kg)
|
5 to 10 mg/kg | 7.5 (7.5) | 12 hourly | Oral | - |
Neonatal Dosage (3kg)
|
5 to 10 mg/kg | 7.5 (7.5) | 12 hourly | Oral | - |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Carbamazepine
Back to top
Previous Drug Generic - Next Drug Generic